Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature

Background Actinomyces turicensis is rarely responsible of clinically relevant infections in human. Infection is often misdiagnosed as malignancy, tuberculosis, or nocardiosis, therefore delaying the correct identification and treatment. Here we report a case of a 55-year-old immunocompetent adult with brain abscess caused by A. turicensis. A systematic review of A. turicensis infections was performed. Methods A systematic review of the literature was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The databases MEDLINE, Embase, Web of Science, CINAHL, Clinicaltrials.gov and Canadian Agency for Drugs and Technology in Health (CADTH) were searched for all relevant literature. Results Search identified 47 eligible records, for a total of 67 patients. A. turicensis infection was most frequently reported in the anogenital area (n = 21), causing acute bacterial skin and skin structure infections (ABSSSI) including Fournier’s gangrene (n = 12), pulmonary infections (n = 8), gynecological infections (n = 6), cervicofacial district infections (n = 5), intrabdominal or breast infections (n = 8), urinary tract infections (n = 3), vertebral column infections (n = 2) central nervous system infections (n = 2), endocarditis (n = 1). Infections were mostly presenting as abscesses (n = 36), with or without concomitant bacteremia (n = 7). Fever and local signs of inflammation were present in over 60% of the cases. Treatment usually involved surgical drainage followed by antibiotic therapy (n = 51). Antimicrobial treatments most frequently included amoxicillin (+clavulanate), ampicillin/sulbactam, metronidazole or cephalosporins. Eighty-nine percent of the patients underwent a full recovery. Two fatal cases were reported. Conclusions To the best of our knowledge, we hereby present the first case of a brain abscess caused by A. turicensis and P. mirabilis. Brain involvement by A. turicensis is rare and may result from hematogenous spread or by dissemination of a contiguous infection. The infection might be difficult to diagnose and therefore treatment may be delayed. Nevertheless, the pathogen is often readily treatable. Diagnosis of actinomycosis is challenging and requires prompt microbiological identification. Surgical excision and drainage and antibiotic treatment usually allow for full recovery. Supplementary Information The online version contains supplementary material available at 10.1186/s12879-024-08995-w.


Background
Actinomyces are filamentous Gram-positive anaerobic bacteria [1], generally found as commensals of the oropharynx and gastrointestinal or urogenital tracts [2].Actinomycosis is a non-opportunistic and generally polymicrobial progressive granulomatous disease, characterized by subacute or chronic abscess formation, frequently misdiagnosed as malignancy, tuberculosis, or nocardiosis [1,3].It is characterized by tiny yellow clumps called sulfur granules, constituted by a biofilm of bacteria.These, together with necrosis and filamentous Gram-positive fungal-like bacteria, are the typical microscopic findings [3].
Actinomycosis generally involves the cervicofacial region (50%), the thoraco-pulmonary (30%) or the abdominopelvic tract (20%) [1].The infection is acquired by minor trauma or aspiration rather than via hematogenous spread [4].Actinomyces israelii is the most common species in human infections and in most clinical forms of actinomycosis, while A. turicensis is rarely responsible for clinically relevant infections in humans [3,4].
The disease is generally readily treatable but often misdiagnosed [2].The microbiological identification of the pathogen is mandatory, especially since the infection is often polymicrobial.In addition to culture, which takes at least 5 days and up to 15-20 days and could frequently result sterile, genotypic methods, such as comparative 16S ribosomal RNA (rRNA) gene sequencing and matrix-assisted laser desorption ionization timeof-flight (MALDI-TOF), are quicker and more accurate tools for Actinomyces identification.Actinomyces generally retain sensitivity to a wide spectrum of antimicrobials, including β-lactams, clarithromycin, erythromycin, doxycycline, and clindamycin.Long-term treatments are generally required, in addition to surgical debridement.
We report the case of a 55-year-old man with polymicrobial brain abscesses involving Actinomyces turicensis; to the best of our knowledge this is the first case in an adult patient with a history of previous alcohol abuse but no other reasons for immunosuppression.We also performed a systematic review of the literature, to summarize cases of infections due to A. turicensis.Because of the paucity of reports, we believe this work might be of interest to Infectious Diseases and Internal Medicine practitioners, to better understand the clinical presentations, diagnostic approach, and current treatment strategies of actinomycosis due to A. turicensis.

Case report
A 55-year-old man with a history of alcohol abuse and recurrent otitis was found on the ground and brought to the emergency room with confusion and seizures.On physical examination, he presented with hypotension and severe hypothermia.He had a Glasgow Coma Scale (GCS) of 8 and was intubated for airway protection.The initial laboratory analysis revealed an increase in inflammatory markers (white blood cell Brain computed tomography (CT) was performed, which showed two brain lesions in the left temporal-occipital site, measuring 3.9 × 1.8 cm and 2.4 × 1.5 cm respectively, with vasogenic edema and 0.9 cm left-to-right midline shift.Signs of inflammation of the paranasal sinuses were also reported (Fig. 1).
Chest and abdominal CT scan were also performed in order to rule out local pathologies and possible septic embolisms.Blood cultures resulted negative and transthoracic echocardiogram showed no vegetations or signs of endocarditis.Serology for HIV and Toxoplasma gondii resulted negative.Antiedema (mannitol) and anticonvulsant (valproate) therapy was initiated along with empiric antibiotic treatment with ceftriaxone, 2 g every 12 hours, metronidazole, 500 mg every 6 hours, and linezolid 600 mg every 12 hours.The culture of the brain abscess aspirate, collected during neurosurgery, identified Actinomyces turicensis and Proteus mirabilis on two different samples.Specifically, an intraoperative sample was collected in Amies elution medium and cultivated on three agar plates (Sabouraud dextrose agar, Columbia CNA agar and MacConkey agar), while another sample was collected in the absence of medium and cultivated on the same plates plus two additional ones (Chocolate agar and microaerophilic Columbia CNA agar).The plates were incubated at 37° degrees and first bacterial growth was observed at 36 hours.Microbiological identification was performed by MALDI-TOF (Bruker Biotyper ® ), showing high log (score) value (2.17 and 1.97 for each sample respectively).The antimicrobial susceptibility testing was performed by microdilution and Vitek-2 (bioMerieux ® ) automated system respectively for the anaerobic and the aerobic bacteria (Table 1).
Nevertheless, the pathogen is often readily treatable.Diagnosis of actinomycosis is challenging and requires prompt microbiological identification.Surgical excision and drainage and antibiotic treatment usually allow for full recovery.
After obtaining the antimicrobial susceptibility test results, antibiotic therapy was simplified to ceftriaxone 2 g every 12 hours.Metronidazole and linezolid were discontinued.
After treatment optimization, the patient developed a fever and an initially vesiculopapular, then necrotizing, lesion of the upper lip and oral cavity (Fig. 2).
In the suspicion of a herpetic lesion, patient was started on acyclovir for 5 days, with progressive resolution of the lesion.To rule out a possible cutaneous involvement by A. turicensis, a wound swab was performed, resulting positive for Herpes simplex virus-1 (HSV-1) and a carbapenem-resistant Acinetobacter baumannii.Therefore, antimicrobial therapy was enhanced with the addition of ampicillin/sulbactam 3 g every 6 hours for improved coverage of both the brain abscess (A.turicensis) and the mucosal lesion isolate (A.baumannii).Five weeks after surgery, a brain magnetic resonance (MR) showed a reduction of the abscesses and resolution of edema and midline shift (Fig. 3).
The patient was then discharged to a neurorehabilitation facility with indication to continue the antimicrobial treatment with oral amoxicillin-clavulanate for a total of 8 weeks of therapy.

Materials and methods
The present study was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [5].

Search strategy and database selection
The search was conducted on the databases MEDLINE, EMBASE, Web of Science, CINAHL, Clinicaltrials.gov and Canadian Agency for Drugs and Technology in Health (CADTH), including all available records from inception to August 30th, 2023.Each included database was searched with the search term "Actinomyces turicensis" as an all-terms strategy.No filter was applied to the search engines.The search strategy as elaborated by the search engine, together with the corresponding records found divided by database is available in additional files (see Additional file 1).
Obtained records were merged on the online tool Rayyan, where duplicates were identified and removed from the included list.The first round of selection for relevance and eligibility was performed on the same platform [6].Search and selection were performed in blind.Discrepancies in selection were resolved by discussion.A list of records obtained after the primary screening by title and abstract was then downloaded and entered into a computerized database for further analysis by reading the full text of the study.A final list of included records was then generated, and each study was examined for relevant data.Extracted information included author and journal information, year, study design, demographic information about included patient/s, site of infection, clinical presentation, diagnostic procedures, treatment, and outcome.Additional anamnestic information about possible predisposing conditions was also gathered.All

Inclusion and exclusion criteria
Records were identified as eligible if they reported clinical data about infections by A. turicensis.No restrictions were made in terms of study design, peer-review, year of publication, country, language, patient age, or type of patient.In vitro or animal studies were excluded.Records reporting aggregated data only were excluded as well.

Quality appraisal of included studies
Included studies were evaluated for their risk of bias by means of the most appropriate eligible reference scale when their design was either interventional or observational.For observational and randomized studies, the Newcastle-Ottawa scale (NOS) and the Cochrane Risk of Bias Tool 2 (ROB2) were used, respectively [7,8].The risk of bias analysis was performed, in blind, by AI, LVR and ADL.Discrepancies were solved by discussion.

Results
Our search on the six databases has identified 215 records, of which 103 were duplicates and were removed.Therefore, 112 records were screened for relevance and eligibility from the analysis of abstract and title only, resulting in 63 records.A subsequent examination of the relevant data in the full text was conducted, resulting in the exclusion of 16 records.At the end of the study selection process, 47 records were included in the systematic review.A flowchart describing the selection process is reported below (Fig. 4).Included records were published between 2002 and 2023, with a prevalence in the last 5 years (26/47, 55%).Most of the studies were conducted in the USA (19/47, 40%), Europe (15/47, 32%) and China (3/47, 6%).Among  2 and 3).Some of the included cases did not provide enough information about immunosuppression conditions, symptoms, or treatments; therefore, the lack of data was considered when calculating the incidences, to minimize underestimation of the data.

Demographic features and underlying conditions
Published cases showed an almost equal distribution of males and females (35 vs. 32) with a median age of 42 (IQR .From the analysis of the patient anamnestic data, 21 patients (21 out of the 52 patients for which data was available, i.e. 40%) resulted to have had some cause of comorbidity or immunosuppression, particularly smoking (9), diabetes (6), obesity (5), chemotherapy or immunotherapy (4), high dose steroids (3), alcohol abuse (3).Moreover, in relation to the site of infection, a supposed predisposing condition was reported in 27 patients (27/52, 52%).No information about predisposing condition or immunosuppression were reported for 15 patients.

Treatment
Out of the 67 cases described in the literature, abscess drainage was performed in 10 patients (15%), surgical debridement was performed in 41 cases (61%), an antibiotic approach without surgery was chosen for 15 patients (22%), while no information about surgical procedures was reported for one patient.Surgery was considered curative, i.e. without any antibiotic therapy, in 8 out of 67 patients, though insufficient data was reported for the antibiotic treatment for 11 patients.Specifically, 4 received an unspecified broad-spectrum antibiotic regimen, while for 7 patients no data was reported.
In the other 48 cases, a wide range of antibiotic use was reported, as summarized in Table 4.
Broad-spectrum antibiotics, active on both Grampositive and Gram-negative bacteria, were the most frequent first choice treatment, favoring intravenous administration in severe infections.Particularly, piperacillin/tazobactam was used in 7 patients, vancomycin was prescribed in 6 cases, carbapenems where the treatment of choice in 5 patients, while metronidazole or cephalosporin were used in 3 cases each.Regarding targeted therapy, the most frequently administered antibiotics were amoxicillin/clavulanate (n.17 cases), amoxicillin (n.13 cases), ampicillin/sulbactam (n.6 cases), penicillin (n.6 cases) and ampicillin (n. 4 cases).Metronidazole (n.15 cases) or cephalosporin (n.6 cases) were added in case of suspected or documented polymicrobial infections.

Discussion and conclusions
To the best of our knowledge, this is the first case in the literature of a brain abscess caused by A. turicensis and P. mirabilis in an adult patient.Brain involvement in actinomycosis is uncommon [57,58], generally resulting from hematogenous spread or contiguous infection of the ear, sinus, and cervicofacial region [46,58,59].In our case, the brain CT showed inflammation of the paranal sinuses but excluded ear involvement, even if a history of frequent otitis was reported.Brain abscesses caused by opportunistic pathogens are frequently in patient with Human Immunodeficiency virus (HIV) infection or other causes of immunosuppression, whereas bacteria are the most common cause in immunocompetent patients [60].While actinomycosis is a non-opportunistic disease, central nervous system involvement is very rare.Therefore, possible causes of immunosuppression must always be excluded.Our patient had a history of alcohol abuse [61,62], which is considered a pro-inflammatory and nutritionally impaired condition often associated with immune deficiency.
The diagnosis of actinomycosis is challenging and requires an invasive approach for diagnosis.Literature suggests a surgical intervention for any brain abscess measuring at least 2.5 cm in diameter [63,64].Our patient underwent surgical excision of abscesses with consequent microbiological identification.Brain abscesses are frequently polymicrobial [46,65,66]; indeed P. mirabilis was also identified in our case [66].
Furthermore, growth of Actinomyces is generally slow and the bacteriological identification is difficult.Culture could frequently result sterile due to previous antibiotic therapy, concomitant microorganisms and inadequate sampling or incubation conditions.Surgical sampling of biopsy or pus seems to be the most appropriate clinical specimen [3].
Although often difficult to diagnose, actinomycosis is generally readily treatable, showing susceptibility to many antimicrobials including β-lactams, clarithromycin, erythromycin, doxycycline, and clindamycin.Therefore, thanks to the wide susceptibility and availability of treatment, several are the drugs of choice and there is no univocal indication.However, penicillin G or amoxicillin are the most used [3].
In our case, ceftriaxone was considered as target therapy with addiction to ampicillin/sulbactam for a week, as strengthening of the brain abscesses treatment.The prompt clinical and laboratory response in our patient allowed the switch to oral therapy with amoxicillin-clavulanic acid, which has proven to be non-inferior to standard intravenous treatment [67].
Our systematic review of the literature identified 47 articles reporting infections caused by A. turicensis.All included records are case reports (43) and case series (4), with an increased number of published papers in the last 20 years, probably due to the improvement of microbiological techniques, spectrometry, and molecular assay, that allow to better identification of Actinomyces species.Since the diagnosis of actinomycosis requires bacteriological identification, a lack of correct microbiological data, in the past, may have led to a misinterpretation of the risk and an underestimate of the incidence.
Although A. israelii is the main cause of disease within the species [4], we identified 67 cases of infections due to A. turicensis.From the present literature revision, most A. turicensis cases were anogenital, gynecological and urinary tract infections (30), lung infections (8) or cervicofacial infections (5).
As reported in the literature, actinomycosis is generally due to local dissemination of the pathogen rather than hematogenous spread [4].Among the analyzed articles, a concomitant bacteremia was indeed found in 10% (7/67) of cases only, while a predisposing condition of local dissemination was supposed in at least 40% (27/52) of cases.Notably, while actinomycosis is a non-opportunistic disease, a reason for immune system impairment has been found in at least 52% (21/52%) of the cases.
Interestingly, only two central nervous system infections were reported among the included records, both presenting a history of ear infections (i.e.mastoiditis and otitis).In our cases, although a previous history of recurrent otitis was reported, no acute ear infection was present at patient admission.Concerning treatment options and outcome, a wide range of therapies is reported and a relatively low mortality (5%), confirming to be a readily treatable infection when promptly diagnosed [2].
In 76% of cases drainage or surgical debridement was performed, representing not only a therapeutical approach but also as a diagnostic procedure.
In conclusion, diagnosis of actinomycosis is challenging and requires prompt microbiological identification.Surgical excision or drainage together with long-term antibiotics is essential to achieve clinical recovery.Further investigations are needed to assess the optimal antibiotic regimen and its duration.

Fig. 2
Fig. 2 Vesiculopapular and necrotic lesions of the oral cavity and perioral area

Table 1
Antimicrobial susceptibility testing for A. turicensis and P. mirabilis isolated on patient extracted information was then summarized in figures and tables and added to the present study.

Table 2
Demographic features and underlying conditions of the patientsCOPD chronic obstructive pulmonary disease, IQR interquartile range, N. A not available

Table 3
Clinical presentation and microbiological findings